92 related articles for article (PubMed ID: 20568396)
1. [The plasma levels and diagnostic utility of selected hematopoietic growth factors in endometrial cancer patients and with myoma uteri].
Ławicki S; Bedkowska GE; Gacuta-Szumarska E; Czygier M; Szmitkowski M
Pol Merkur Lekarski; 2010 May; 28(167):354-8. PubMed ID: 20568396
[TBL] [Abstract][Full Text] [Related]
2. [The plasma levels and diagnostic utility of stem cell factor in patients with endometrial cancer and myoma uteri].
Ławicki S; Bedkowska GE; Gacuta-Szumarska E; Czygier M; Szmitkowski M
Pol Merkur Lekarski; 2009 Jun; 26(156):609-15. PubMed ID: 19711726
[TBL] [Abstract][Full Text] [Related]
3. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2010; 67(12):1314-8. PubMed ID: 21591359
[TBL] [Abstract][Full Text] [Related]
4. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
Lawicki S; Bedkowska E; Gacuta-Szumarska E; Knapp P; Szmitkowski M
Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612
[TBL] [Abstract][Full Text] [Related]
5. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
[TBL] [Abstract][Full Text] [Related]
6. [The plasma levels and diagnostic utility of stem cell factor and macrophage--colony stimulating factor in endometrial cancer patients].
Lawicki S; Bedkowska E; Gacuta-Szumarska E; Czygier M; Szmitkowski M
Przegl Lek; 2007; 64(12):987-90. PubMed ID: 18595499
[TBL] [Abstract][Full Text] [Related]
7. Hematopoietic cytokines as tumor markers in gynecological malignancies: a multivariate analysis with ROC curve in endometrial cancer patients.
Lawicki S; Będkowska GE; Gacuta-Szumarska E; Szmitkowski M
Growth Factors; 2012 Feb; 30(1):29-36. PubMed ID: 22010785
[TBL] [Abstract][Full Text] [Related]
8. [The plasma levels and diagnostic utility of granulocyte colony stimulating factor (G-CSF) and macrophage - colony stimulating factor (M-CSF) in ovarian cancer patients].
ławicki S; Czygier M; Gacuta-Szumarska E; Knapp P; Szmitkowski M
Pol Merkur Lekarski; 2006 Nov; 21(125):465-8. PubMed ID: 17345841
[TBL] [Abstract][Full Text] [Related]
9. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
10. [The plasma levels of granulocyte-colony stimulating factor and granulocyte-macrophage colony stimulating factor in breast cancer patients].
Ławicki S; Czygier M; Omyła J; Bedkowska E; Szmitkowski M
Pol Merkur Lekarski; 2007 Oct; 23(136):259-63. PubMed ID: 18293847
[TBL] [Abstract][Full Text] [Related]
11. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
[TBL] [Abstract][Full Text] [Related]
12. Predictive power of sexual hormones and tumor markers in endometrial cancer.
Kanat-Pektas M; Yenicesu O; Gungor T; Bilge U
Arch Gynecol Obstet; 2010 Apr; 281(4):709-15. PubMed ID: 19777250
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic growth factors in colorectal cancer patients.
Mroczko B; Szmitkowski M; Okulczyk B
Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Jurkowska G
Clin Chem Lab Med; 2005; 43(2):146-50. PubMed ID: 15843207
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
Oh JC; Wu W; Tortolero-Luna G; Broaddus R; Gershenson DM; Burke TW; Schmandt R; Lu KH
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of G-CSF measurement in the sera of colorectal cancer and adenoma patients.
Mroczko B; Groblewska M; Wereszczynska-Siemiatkowska U; Kedra B; Konopko M; Szmitkowski M
Clin Chim Acta; 2006 Sep; 371(1-2):143-7. PubMed ID: 16603145
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum CA-125 levels in treating endometrial cancer.
Powell JL; Hill KA; Shiro BC; Diehl SJ; Gajewski WH
J Reprod Med; 2005 Aug; 50(8):585-90. PubMed ID: 16220763
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic cytokines as tumor markers in breast malignancies. A multivariate analysis with ROC curve in breast cancer patients.
Ławicki S; Będkowska GE; Wojtukiewicz M; Szmitkowski M
Adv Med Sci; 2013; 58(2):207-15. PubMed ID: 23846151
[TBL] [Abstract][Full Text] [Related]
19. [The plasma level of sL-selectin, myeloperoxidase (MPO) and granulocyte-colony stimulating factor (G-CSF) in gynecological cancer patients].
Czygier M; Ławicki S; Gacuta-Szumarska E; Bedkowska E; Szmitkowski M
Przegl Lek; 2010; 67(3):184-6. PubMed ID: 20687382
[TBL] [Abstract][Full Text] [Related]
20. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
